Skip to Content
Showing 1-10 of 16

Sorted By:


    A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome)


    Algorithm using LinQ Sensors for Evaluation And Treatment of Heart Failure


    The primary objective of this study is to assess the safety and efficacy of the VITARIAâ„¢ system when added to stable, guideline-directed medical therapy for patients with heart failure and reduced heart muscle function.


    The purpose of this study is to evaluate the effectiveness and safety of a home based infusion device for the delivery of a subcutaneous (under the skin) diuretic (Furoscix) in patients with chronic heart failure and fluid overload.


    Balance is a double blind, placebo controlled phase 3 study of Akcea-APOCIII-LRX administered subcutaneously to patients with familial chylomicronemia syndrome (FCS).


    The purpose of this clinical investigation is to develop valid scientific evidence for the safety and effectiveness of the BAROSTIM NEO System delivered by the BATwire Implant Kit (BATwire Kit) in subjects with heart failure.


    Building a Repository of Cardiac Phase Signals for Algorithm Development Recruiting Mostly Female Subjects (CADFEM)


    COORDINATE-Diabetes is a cluster-randomized clinical trial testing the effectiveness of an innovative, clinic level intervention to improve the management of type 2 Diabetes in patients with cardiovascular disease.

  • CORE

  • DAPA TIMI 68

    This study is a multicenter, randomized, double-blind , placebo-controlled trial to evaluate the effect of in-hospital initiation of Dapagloflozin on clinical outcomes in patients with heart failure who have been stabilized during hospitalization for acute heart failure.